Literature DB >> 9710809

Aging impairs functional, metabolic and ionic recovery from ischemia-reperfusion and hypoxia-reoxygenation.

J P Headrick1.   

Abstract

Functional and metabolic responses to ischemia-reperfusion and hypoxia-reoxygenation were studied in Langendorff perfused hearts from mature (2-4 months) and aged (18-24 months) Wistar rats. Hearts were subjected to 20 min global ischemia or hypoxia followed by 30 min reperfusion or reoxygenation. Cellular metabolism was assessed by 31P-NMR spectroscopy. Normoxic function, phosphate metabolite levels, and cytosolic free energy state (delta GATP) were comparable in both age groups, although free [5'-AMP] and purine efflux were elevated in aged hearts. There were no aging-related differences in phosphate metabolite levels, pH or delta GATP during ischemia or hypoxia. Nevertheless, ischemic and hypoxic contracture tended to be higher in aged hearts. After reperfusion, heart rate x left-ventricular pressure recovered to 55% of pre-ischemia in mature hearts, and only 25% in aged hearts. After reoxygenation, function recovered to 75% in mature hearts and 55% in aged hearts. Recoveries of cellular [ATP], [phosphocreatine], [inorganic phosphate] and [Mg2+] were impaired, and delta GATP was consistently depressed in aged v mature hearts, Impaired recovery of delta GATP was associated with enhanced purine efflux in aged hearts. Post-ischemic Na+ and Ca2+ accumulation was also increased by 30-40% in aged hearts. Tissue damage assessed by post-ischemic creatine kinase efflux was modest in mature hearts (< 2% total tissue activity) and was 2.5-fold higher in aged hearts. The data show that: (i) aging reduces contractile recovery from ischemia/hypoxia; (ii) this is unrelated to the metabolic insult during ischemia/hypoxia, but parallels reduced recovery of delta GATP [inorganic phosphate], [Mg2+]i [Na+] and [Ca2+]; and (iii) increased purine catabolism may contribute to poor metabolic recovery in aged hearts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9710809     DOI: 10.1006/jmcc.1998.0710

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  17 in total

Review 1.  Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.

Authors:  Louise E See Hoe; Lauren T May; John P Headrick; Jason N Peart
Journal:  Br J Pharmacol       Date:  2016-09-09       Impact factor: 8.739

2.  Middle age aggravates myocardial ischemia through surprising upholding of complex II activity, oxidative stress, and reduced coronary perfusion.

Authors:  Evangelia Mourmoura; Marie Leguen; Hervé Dubouchaud; Karine Couturier; Damien Vitiello; Jean-Luc Lafond; Melanie Richardson; Xavier Leverve; Luc Demaison
Journal:  Age (Dordr)       Date:  2010-09-29

3.  Aldose reductase and AGE-RAGE pathways: central roles in the pathogenesis of vascular dysfunction in aging rats.

Authors:  Kellie McCormick Hallam; Qing Li; Radha Ananthakrishnan; Anastasia Kalea; Yu S Zou; Srinivasan Vedantham; Ann Marie Schmidt; Shi Fang Yan; Ravichandran Ramasamy
Journal:  Aging Cell       Date:  2010-08-15       Impact factor: 9.304

4.  Aldose reductase pathway contributes to vulnerability of aging myocardium to ischemic injury.

Authors:  Radha Ananthakrishnan; Qing Li; Teodoro Gomes; Ann Marie Schmidt; Ravichandran Ramasamy
Journal:  Exp Gerontol       Date:  2011-05-10       Impact factor: 4.032

5.  Impaired p38 MAPK/HSP27 signaling underlies aging-related failure in opioid-mediated cardioprotection.

Authors:  Jason N Peart; Eric R Gross; John P Headrick; Garretta J Gross
Journal:  J Mol Cell Cardiol       Date:  2007-02-28       Impact factor: 5.000

6.  Dysfunctional survival-signaling and stress-intolerance in aged murine and human myocardium.

Authors:  Jason N Peart; Salvatore Pepe; Melissa E Reichelt; Nikkie Beckett; Louise See Hoe; Victoria Ozberk; Ingrid R Niesman; Hemal H Patel; John P Headrick
Journal:  Exp Gerontol       Date:  2013-12-04       Impact factor: 4.032

Review 7.  Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart.

Authors:  John P Headrick; Louise E See Hoe; Eugene F Du Toit; Jason N Peart
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

Review 8.  Aldose reductase, oxidative stress and diabetic cardiovascular complications.

Authors:  Srinivasan Vedantham; Radha Ananthakrishnan; Ann Marie Schmidt; Ravichandran Ramasamy
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2012-09

9.  Opposing effects of age and calorie restriction on molecular determinants of myocardial ischemic tolerance.

Authors:  Jason N Peart; Louise See Hoe; Salvatore Pepe; Peter Johnson; John P Headrick
Journal:  Rejuvenation Res       Date:  2012-01-11       Impact factor: 4.663

10.  Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors.

Authors:  Giuseppe De Luca; Arnoud W J van't Hof; Kurt Huber; C Michael Gibson; Francesco Bellandi; Hans-Richard Arntz; Mauro Maioli; Marko Noc; Simona Zorman; Gioel Gabrio Secco; Uwe Zeymer; H Mesquita Gabriel; Ayse Emre; Donald Cutlip; Tomasz Rakowski; Maryann Gyongyosi; Dariusz Dudek
Journal:  Heart Vessels       Date:  2013-03-14       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.